נובוגרד 2 מ"ג/500 מ"ג
Country: Iżrael
Lingwa: Ebrajk
Sors: Ministry of Health
Xi dokumenti għal dan il-prodott mhumiex disponibbli bħalissa, tista 'tibgħat talba lis-servizz tal-konsumatur tagħna u aħna ninnotifikawkom malli nkunu nistgħu niksbuhom.
Ibgħat talba.
Ibgħat talba.
Ingredjent attiv:
METFORMIN HYDROCHLORIDE 500 MG; REPAGLINIDE 2 MG
Disponibbli minn:
NOVO NORDISK LTD
Kodiċi ATC:
A10BA02
Għamla farmaċewtika:
TABLETS
Rotta amministrattiva:
PER OS
Manifatturat minn:
NOVO NORDISK A/S, DENMARK
Grupp terapewtiku:
METFORMIN
Indikazzjonijiet terapewtiċi:
NovoGard is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 mellitus who are already treated with a meglitinide and metformin HCl or who have inadequate glycemic control on a meglitinide alone or metformin HCl alone.
Data ta 'l-awtorizzazzjoni:
2011-05-01
